Clinical Trial Update: Phase 3 Single Arm, Open Study on vYF in Adults [Phase 3]

View source ↗

Summary

Phase 3 single-arm, open-label trial of the vYF yellow fever vaccine in adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Yellow Fever

Drugs mentioned

• vYF

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Yellow Fever | Phase 3 | Status: COMPLETED